Clinical Trial Update: A Study of Quetiapine for the Treatment of Mood Disorders in Adolescents [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating quetiapine for mood disorders in adolescents has completed. The study was sponsored by the University of Cincinnati.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mood Disorders

Drugs mentioned

• Quetiapine (quetiapine)

Snippet

Sponsor: University of Cincinnati | Conditions: Mood Disorders | Phase 3 | Status: COMPLETED